Product Description
Cagrilintide | 10mg
Researching Appetite Regulation and Metabolic Control
What It Does
Cagrilintide is being studied for its ability to activate amylin receptors in the brain, promoting a strong sense of fullness and reduced food intake. It is a focus in research exploring appetite regulation, metabolic control, and combination approaches to weight management.
What Researchers Explore
- Appetite suppression and satiety signaling
- Slowed gastric emptying mechanisms
- Reduction in food cravings
- Additive weight loss effects in combination research
- Post-meal glucose regulation
Technical Background
Cagrilintide is a 37-amino acid long-acting amylin analog featuring a C18 fatty diacid chain and stabilizing structural modifications to improve peptide stability and reduce aggregation. It functions as a potent agonist at amylin receptors (AMY1–3) and calcitonin receptors.
It activates receptor populations in key brain regions involved in appetite regulation, including the area postrema, nucleus of the solitary tract, and arcuate nucleus. These pathways influence both homeostatic and hedonic feeding behavior. Clinical research has demonstrated dose-dependent weight loss effects in once-weekly administration models.
Common Research Applications
- Amylin receptor (AMY1–3) signaling research
- Calcitonin receptor agonism studies
- Appetite regulation via hypothalamic and brainstem pathways
- Long-acting lipidated peptide formulation research
- Hedonic vs homeostatic appetite control
- Combination GLP-1 and amylin pathway research
Product Properties
Purity: 99%+ HPLC
Form: Lyophilized Powder
Size: 10mg
Category: Metabolic / Appetite Research
Frequently Studied Together
- Semaglutide (GLP-1 receptor agonist research)
- Tirzepatide (dual GIP/GLP-1 pathway research)
- Retatrutide (multi-agonist metabolic pathway research)